Thank you for subscribing to our blog.
We’ll hit your inbox next week with our latest post.

Latest Insights and Updates Delivered to your Inbox!

Subscribe now for exciting weekly industry news!

World Cancer Day 2024: 5 Recent Advances in Cancer Research and Treatment
World Cancer Day 2024 is celebrated to bring awareness to a global health crisis claiming around 10 million lives annually. As the world copes with the rising burden of cancer cases, the landscape of cancer research is witnessing transformative innovations. What is a Clinical Trial for Cancer? A clinical trial for cancer is a carefully designed res...
Biosimilar CRO: Biosimilar Clinical Trials Excellence for Levim Biotech
Navitas Life Sciences provides the right platform for clinical research excellence, where innovation meets precision. At Navitas Life Sciences, we're at the forefront of revolutionizing clinical research management systems, collaborating seamlessly to drive efficient biosimilar clinical trials to be among the leading pharma CROs. “We found N...
3 Ways to Lower Clinical Trials Cost in 2024
Clinical trials trends in 2024 include management of trials for breakthroughs like personalized cancer treatments and advanced nanotechnology on the horizon. However, the journey through clinical trials presents significant financial challenge for many life science and biotech companies. How much do clinical trials cost? Clinical trials cost can va...
Top 8 Clinical Trial Trends for 2024 and Beyond
The clinical trials ecosystem is undergoing a transformative shift in 2024, fueled by technological advancements, regulatory updates, and an increasing focus on patient-centricity. As medical research continues to evolve, it is crucial to stay informed about the latest trends in clinical trials shaping the field. In this blog, we delve into the top...
5 Must Have Features in an Oncology CRO
Navitas Life Sciences joins The World Health Organization in raising awareness about cervical cancer this January, Cervical Cancer Awareness Month. According to the WHO, 604,000 were affected with cervical cancer globally in 2020, and it is the fourth most common type of cancer. In the UK, around 3,200 new cervical cancer cases are identified every...
The Impact of Generative AI in Clinical Trials
Generative AI in clinical trials, a subset of Artificial Intelligence (AI), holds promise as clinical trials not only should be flexible and adaptable but also cost-effective, catering to the diverse needs of various stakeholder groups. The intricacies of clinical trials, inherently labor-intensive, complex, and heavily regulated, make this task pa...
Top Pharma Articles of 2023: Year in review
Clinical Research Organizations (CROs) play a significant role in clinical research and in transforming healthcare. Ranging from catering to specialized niche pharmaceutical companies to expansive global pharma companies, CROs serve as the driving force behind the journey of new drugs and medical devices from conception to FDA approval. CRO’...
Managing Efficient Clinical Trials with CROs: Guide to Finding Top Clinical Research Organizations in 2024
Clinical trials present a complex landscape that demands meticulous navigation through the intricacies of protocol development, regulatory compliance, and trial management—an inherently formidable task. It is in this intricate terrain that Contract Research Organizations (CROs) assume a pivotal role, emerging as indispensable partners for sp...
Designing Efficient Clinical Trials for Rare Diseases’ Orphan Drug Development
In this exciting blog, we focus on the research and innovation in rare disease clinical trials. Navitas Life Sciences’ commitment to accelerating pharmaceutical breakthroughs globally is reflected in our extensive experience of 600+ clinical trials, expertise in 20+ therapeutic areas, and a proven track record of collaborating with biopharma...
Navitas Life Sciences Supports Efficient Clinical Trials for Advancing Treatment for HIV/AIDS
The World Health Organization states that nearly 39 million people live with HIV/AIDS globally (2022), with 630,000 people dying due to HIV related causes, necessitating the need for improved treatment and care. Navitas Life Sciences has been supporting the efficient management of clinical trials for small to large pharma and life sciences companie...

Solutions

Advisory Services

Clinical Development

Post Marketing

Therapeutics

Core Therapeutics

Interdisciplinary Therapeutics

Niche Therapeutics

Sectors

Governance

About Us